I have Type 1 diabetes. I love to write. I’m happy when I am helping others. I speak up when it’s important. I have a passion for sharing knowledge and learning new technology. I was BORN to BLOG!

I’ve met so many other T1Ds on this journey who are cool and love to help others. We put our heads and hearts together … to bring more resources and knowledge to our amazing diabetes community. We’re making improvements every day … come back often, let us know what you think. And my gratitude for my amazing webmaster, Dave (an honorary T1D)!

And thank you for stopping by!
— Joanne Laufer Milo, The Savvy Diabetic

Savvy Updates 6/12/23: NovoNordisk Acquires BioCorp, Go Bionic Interview with Stacey Simms, Alexander Zverev Can’t Inject Insulin on Tennis Court, Hyperglycemia, Metformin & Long Covid, KnowLabs Gen1 Prototype, Residual Insulin, Insect-inspired Microphones, Non-Invasive CGMs Just a Dream?

Savvy Updates 6/12/23: NovoNordisk Acquires BioCorp, Go Bionic Interview with Stacey Simms, Alexander Zverev Can’t Inject Insulin on Tennis Court, Hyperglycemia, Metformin & Long Covid, KnowLabs Gen1 Prototype, Residual Insulin, Insect-inspired Microphones, Non-Invasive CGMs Just a Dream?

Novo Nordisk says in talks to acquire French device-maker Biocorp for $165M by Elise Reuter for MedTechDive.com, 5 June 2023. Novo Nordisk wants to innovate faster and develop new connected devices, and expects that Biocorp would complement its internal efforts, said...

read more
Savvy Updates 5/30/23: Metronics Buys Patch Pump EoFlow, Non-Invasive CGM, PIP, The Better Lancet,  Splenda Responds to WHO, Loneliness (and Chat Benches), Impact of Negative Language

Savvy Updates 5/30/23: Metronics Buys Patch Pump EoFlow, Non-Invasive CGM, PIP, The Better Lancet, Splenda Responds to WHO, Loneliness (and Chat Benches), Impact of Negative Language

Medtronic to acquire South Korean wearable insulin patch maker EOFlow by Ravikash for SeekingAlpha.com, 25 May 2023.   Medtronic is acquiring South Korea-based wearable insulin patch maker EOFlow in a deal worth KRW 971B ($738M). The acquisition will...

read more
Savvy Updates 5/22/23: Beta Bionics iLet Bionic Pancreas Approved, GLP-1 / Anticancer?, No More Sugar Substitutes, Bad News Can Make You Sick, Almonds as Healthy Snack

Savvy Updates 5/22/23: Beta Bionics iLet Bionic Pancreas Approved, GLP-1 / Anticancer?, No More Sugar Substitutes, Bad News Can Make You Sick, Almonds as Healthy Snack

FDA Clears iLet Bionic Pancreas System for Type 1 Diabetes by Kristen Monaco for MedPageToday.com, 19 May 2023.   The new iLet Bionic Pancreas system was cleared by the FDA for patients 6 and older with type 1 diabetes, the agency...

read more
Savvy Fun Stuff, 5/17/23:  AI-wearable Humane, Austin Basis (T1D, Ionogels into Batteries & Sensors, “The Marvelous Mrs. Maisel”, Mosquitoes & Coconut

Savvy Fun Stuff, 5/17/23: AI-wearable Humane, Austin Basis (T1D, Ionogels into Batteries & Sensors, “The Marvelous Mrs. Maisel”, Mosquitoes & Coconut

iPhone killer? New AI-wearable Humane hopes to make smartphones obsolete by Christopher McFadden for InterestingEngineering.com, 12 May 2023. A TedTalk that previews a new artificial intelligence-powered wearable called Humane has just been released. Developed by...

read more
Savvy Updates, 5/15/23: Know Labs Study, TIR & Young T1Ds & Insulins, Insulin Resistance, Capsule Studies Microbiome, Insulin Temp Stability, Watermelon Heart-Healthy, Embecta/Tidepool Partner for T2D, Glucomate, Diabetes Epidemic in UK, Legislation to Fix Prior Auth

Savvy Updates, 5/15/23: Know Labs Study, TIR & Young T1Ds & Insulins, Insulin Resistance, Capsule Studies Microbiome, Insulin Temp Stability, Watermelon Heart-Healthy, Embecta/Tidepool Partner for T2D, Glucomate, Diabetes Epidemic in UK, Legislation to Fix Prior Auth

Know Labs reports data from feasibility study of Bio-RFID sensor reported on MedicalDevice-Network.com, 8 May 2023. Know Labs has reported data from a new technical feasibility study of its Bio-RFID sensor technology for non-invasive glucose monitoring, compared to...

read more
Savvy Updates, 5/8/23: CGM Disruptions (Dexcom & Abbott), Japanese Diet & NAFLD, UPFs & Brain Health, Weight Loss Drug $$, Envision Bankruptcy

Savvy Updates, 5/8/23: CGM Disruptions (Dexcom & Abbott), Japanese Diet & NAFLD, UPFs & Brain Health, Weight Loss Drug $$, Envision Bankruptcy

Most adults with diabetes report CGM disruptions due to device problems, medical care by Alexis McKee for Healio.com/endocrinology, 3 May 2024.   More than 80% of adults with diabetes using continuous glucose monitoring reported at least one instance of...

read more
Savvy D Living, 5/3/23: TCOYD on Carbs, Digestive Organs Vary, T1D in Hospital, T1D and Teeth, Burden of T1D Living, About Hair

Savvy D Living, 5/3/23: TCOYD on Carbs, Digestive Organs Vary, T1D in Hospital, T1D and Teeth, Burden of T1D Living, About Hair

TCOYD: All about Carb Counting with Drs. Steve Edelman and Jeremy Pettus These are 2 great videos (among many others) by TCOYD about carbs, carb counting and how to count fiber in your carb counting.  I've always said that T1D would be WAY easier to manage if it...

read more
Savvy Updates 5/1/23:  Lilly Sells Off Baqsimi, Humacyte Biovascular Pancreas, Dexcom Growth, Know Labs Non-Invasive Sensor, Medtronic Resolves FDA Warning Letter, Omnipod GO for T2D, Doctors More Neurotic, Diabetes Standards of Care, 2023

Savvy Updates 5/1/23: Lilly Sells Off Baqsimi, Humacyte Biovascular Pancreas, Dexcom Growth, Know Labs Non-Invasive Sensor, Medtronic Resolves FDA Warning Letter, Omnipod GO for T2D, Doctors More Neurotic, Diabetes Standards of Care, 2023

Lilly sells emergency diabetes drug for $500M by Jonathan Gardner for BioPharmaDive.com, 24 April 2023. Eli Lilly will sell its emergency diabetes treatment Baqsimi to Amphastar Pharmaceuticals for $500 million upfront, the company said, divesting a drug launched...

read more
Savvy Updates 4/24/23: Abbott Libre 3 Reader Cleared, Medtronic MiniMed 780G System Cleared by FDA, Diamyd Precision Medicine Antigen-Specific Immunotherapy, Aspect Biosystems/3D bioprinting, Blackstone Using AI to Control Diabetes, What is Deja Vu?

Savvy Updates 4/24/23: Abbott Libre 3 Reader Cleared, Medtronic MiniMed 780G System Cleared by FDA, Diamyd Precision Medicine Antigen-Specific Immunotherapy, Aspect Biosystems/3D bioprinting, Blackstone Using AI to Control Diabetes, What is Deja Vu?

Abbott gets clearance for Libre 3 reader, opening path to Medicare coverage by Elise Reuter for MedTechDive.com, 17 April 2023.   Since Medicare covers CGMs as durable medical equipment, the devices must include a component, such as a reader, that is...

read more
Share This
Skip to content